UBS Oncology Impact Fund L.P.
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to UBS Oncology Impact Fund L.P.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| HOWL | Sale | 60,733 | $0.98 | $59,518 | Nov 28, 2025 | |
| HOWL | Sale | 55,810 | $1.14 | $63,623 | Nov 10, 2025 | |
| HOWL | Sale | 134,240 | $1.55 | $208,072 | Oct 27, 2025 | |
| 0001808865 | Sale | 60,600 | $27.96 | $1,694,376 | Sep 27, 2021 | |
| CGEM | Sale | 15,757 | $29.46 | $464,201 | Sep 1, 2021 | |
| 0001708493 | Sale | 5,000 | $20.12 | $100,600 | May 21, 2021 | |
| 0001708493 | Sale | 13,528 | $20.72 | $280,300 | Apr 9, 2021 |